Kristien Boelaert

31 - 40 out of 170Page size: 10

Publications

  1. Published

    The SH3 domain of PTTG differentially mediates FGF-2 transactivation and cell transformation

    Kristien Boelaert, Lesley Tannahill, Jasbir Moore, Lawrence Young, Michael Sheppard, Neil Gittoes, Jayne Franklyn & Christopher McCabe, 1 Jan 2002, p. OR 40-42.

    Research output: Contribution to conference (unpublished) › Paper

  2. Published

    PTTG and FGF-2 -novel potential molecular indicators for thyroid cancer

    Kristien Boelaert, Christopher McCabe, Lesley Tannahill, Neil Gittoes, Michael Sheppard & Jayne Franklyn, 1 Jan 2002, p. OR 61-62.

    Research output: Contribution to conference (unpublished) › Paper

  3. Published

    Comparison of mortality in hyperthyroidism during periods of treatment with thionamides and after radioiodine

    Kristien Boelaert, Barbara Torlinska & Jayne Franklyn, May 2013, In: The Journal of clinical endocrinology and metabolism. 98, 5, p. 1869-82 14 p.

    Research output: Contribution to journal › Article › peer-review

  4. Published

    Prevalence and Relative Risk of Other Autoimmune Diseases in Subjects with Autoimmune Thyroid Disease

    Kristien Boelaert, Paul Newby, Matthew Simmonds, Roger Holder, Stephen Gough & Jayne Franklyn, 1 Feb 2010, In: The American Journal of Medicine. 123, 2, p. 183.e1 1 p.

    Research output: Contribution to journal › Article

  5. Published

    Treatment of Graves' Disease with Antithyroid Drugs: Current Perspectives

    Kristien Boelaert, 1 Sep 2010, In: Thyroid. 20, 9, p. 943-946 4 p.

    Research output: Contribution to journal › Editorial

  6. Published

    Sodium iodide symporter (NIS) gene expression is a potential prognostic indicator for thyroid cancer and is inhibited by pituitary tumor transforming gene

    Kristien Boelaert, Lesley Tannahill, Margaret Eggo, Neil Gittoes, Michael Sheppard, Jayne Franklyn & Christopher McCabe, 1 Jan 2003.

    Research output: Contribution to conference (unpublished) › Paper

  7. Published

    A potential role for PTTG/securin in the developing human fetal brain

    Kristien Boelaert, Lesley Tannahill, Kachilele-Linjewile Kachilele, Shiaoyng Chan, Neil Gittoes, Jo Bradwell, Jayne Franklyn, Mark Kilby & Christopher McCabe, 1 Sep 2003, In: FASEB Journal. 17, 12, p. 1631-1639 9 p.

    Research output: Contribution to journal › Article

  8. Published

    The association between serum TSH concentration and thyroid cancer

    Kristien Boelaert, 20 Jul 2009, In: Endocrine-related cancer.

    Research output: Contribution to journal › Article

  9. Published

    WOMEN IN CANCER PROFILE: From bedside to bench and back: my journey in thyroid disease

    Kristien Boelaert, Nov 2016, In: Endocrine-related cancer. 23, 11, p. 9-13

    Research output: Contribution to journal › Special issue › peer-review

  10. Published

    Serum TSH concentration as a novel predictor of malignancy in thyroid nodules investigated by fine needle aspiration

    Kristien Boelaert, Roger Holder, Michael Sheppard & Jayne Franklyn, 5 Sep 2006, In: Journal of Clinical Endocrinology and Metabolism. 91, 11, p. 4295-4301 7 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 ...17 Next